跳至主要内容
临床试验/NCT06626581
NCT06626581尚未招募不适用

A Cross-sectional Study on Iodine Status and Characteristics of Papillary Thyroid Cancer

Shandong Provincial Hospital0 个研究点目标入组 600 人开始时间: 2024年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
600
主要终点
Serum and urine iodine levels

研究概览

简要总结

The effect of iodine on papillary thyroid cancer has been controversial for many years. The investigators designed a cross-sectional study and aimed to explore the relationship between the serum and urine iodine levels and the clinical and molecular characteristics of papillary thyroid cancer.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age range: 18~65 years old, gender not limited;
  • Living in the residential area for at least 5 years;
  • Patients diagnosed clinically with thyroid cancer and scheduled for thyroid surgery, with pathological diagnosis of papillary thyroid cancer;
  • Complete clinical data: including general information, relevant laboratory tests, pathological reports, surgical reports, ultrasound reports, etc.

排除标准

  • Pathological diagnosis of other types of thyroid cancer;
  • Diagnosed with other types of cancer;
  • There are serious comorbidities of the heart, liver, and kidneys;

结局指标

主要结局

Serum and urine iodine levels

时间窗: 1 year from enrollment

TNM staging of papillary thyroid cancer

时间窗: 3 month from enrollment

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Hai-qing Zhang

Chief physician

Shandong Provincial Hospital

相似试验